22 results
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
business transaction is approved by a majority of the members of the target corporation’s board of directors and authorized at an annual or special meeting … combination is approved by the board of directors of the corporation and authorized at an annual or special meeting of stockholders, and not by written
PRE 14A
IMPLQ
Impel Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:11pm
by the stockholders of the Corporation except at a duly called annual or special meeting of stockholders and no action shall be taken by the stockholders … of the Corporation by written consent in lieu of a meeting.
2.Special Meeting of Stockholders. Special meetings of the stockholders of the Corporation may
10-K/A
2022 FY
EX-3.2
IMPLQ
Impel Pharmaceuticals Inc
31 Mar 23
Annual report (amended)
4:21pm
to time, the “Certificate of Incorporation”). The special meeting may be held either at a place, within or without the State of Delaware, or by means … of remote communication as the Board in its sole discretion may determine. Business transacted at any special meeting of stockholders shall be limited
424B5
qovo ayjjcee99jmmzfg
24 May 22
Prospectus supplement for primary offering
4:32pm
S-3
4irx8ak0j7jg7x zpit
16 May 22
Shelf registration
4:49pm
424B4
kc1d2ev15k88a94yb
10 Sep 21
Prospectus supplement with pricing info
4:01pm
DRS
4d1vplp4utfsihbpc
25 Aug 21
Draft registration statement
12:00am
10-Q
EX-3.2
xh3i5hl zrkxxy3
7 Jun 21
Quarterly report
7:17am
10-Q
EX-3.1
jyq3 g7susjvlci
7 Jun 21
Quarterly report
7:17am
424B1
1b3cri7mcjlgh
23 Apr 21
Prospectus with pricing info
4:01pm
S-1
EX-3.1
7au652h2hhi
2 Apr 21
IPO registration
3:04pm
S-1
EX-3.3
4hp8c8p2cv
2 Apr 21
IPO registration
3:04pm